Worldwide, the leading cause of death is ischemic heart disease. Other than medical and surgical management, alternative therapy such as relaxing music has been identified as having an impact on reducing morbidity in ...Worldwide, the leading cause of death is ischemic heart disease. Other than medical and surgical management, alternative therapy such as relaxing music has been identified as having an impact on reducing morbidity in ischemic heart disease. Although several studies have been conducted to find out the impact of music on pain, anxiety, heart rate and stress in myocardial ischaemia, literature on the long term impact of music on severity of symptoms associated with stable angina is very sparse. Therefore, the whole purpose of this study was to determine the long term effects of Indian music on severity of symptoms in patients with stable angina. Methodology: A single blind randomized clinical trial was conducted on 60 patients of 45 to 65 years of age with stable angina. Intervention group (n = 30) listened to a music based on Indian classical system at home twice a day complementary to their regular treatment for a period of one month. Control group (n = 30) was only on their usual treatment. Both groups were assessed prior and one month after the study period for severity of symptoms based on Canadian classification of angina guidelines and their treatment. Results: Severities of symptoms (timing of the chest pain, chest pain during walking and climbing a staircase, the effect of chest pain in day to day physical activities, frequency and the number of GTN used per week and frequency of consultation a doctor for chest pain) were significantly improved in the study group (p < 0.05, p < 0.01) after intervention. However, the control group did not show any significant changes (p > 0.05). Conclusion: Systematically, regular listening of music based on Indian classical system significantly improves the severity of the stable angina symptoms. Hence music has a potential benefit in considering for use as complementary to angina treatment in reducing morbidity.展开更多
CHEK2 (Checkpoint kinase homolog 2) encodes a protein involved in pathways that arrest the cell cycle in response to genomic stress such as DNA damage or replication blocks. Carriers of some of the CHEK2 mutations are...CHEK2 (Checkpoint kinase homolog 2) encodes a protein involved in pathways that arrest the cell cycle in response to genomic stress such as DNA damage or replication blocks. Carriers of some of the CHEK2 mutations are at an increased risk of breast cancer. A mutation in the kinase domain of the CHEK2 gene resulting in the R406H substitution has been reported. However, it is currently unknown whether the substitution alters the function of CHEK2 in vitro. We evaluated the effect of the R406H substitution on the normal function of CHEK2 using a yeast complementation assay. The yeast cells lacking Rad53, the yeast homologue of human CHEK2 were transformed with the wild type as well as plasmids carrying mutations resulting in the R406H, 1100delC, and S428F variants. Yeast cells carrying the R406H variant grew at a rate similar to those carrying the wild type CHEK2, whereas the yeast carrying the S428F and 1100delC mutants grew at a slower rate. These results suggest that, unlike the well-known pathogenic alleles such as 1100delC and S428F, the R406H substitution does not abrogate the function of CHEK2. Therefore, this variant is probably not important in development of breast cancer in women.展开更多
文摘Worldwide, the leading cause of death is ischemic heart disease. Other than medical and surgical management, alternative therapy such as relaxing music has been identified as having an impact on reducing morbidity in ischemic heart disease. Although several studies have been conducted to find out the impact of music on pain, anxiety, heart rate and stress in myocardial ischaemia, literature on the long term impact of music on severity of symptoms associated with stable angina is very sparse. Therefore, the whole purpose of this study was to determine the long term effects of Indian music on severity of symptoms in patients with stable angina. Methodology: A single blind randomized clinical trial was conducted on 60 patients of 45 to 65 years of age with stable angina. Intervention group (n = 30) listened to a music based on Indian classical system at home twice a day complementary to their regular treatment for a period of one month. Control group (n = 30) was only on their usual treatment. Both groups were assessed prior and one month after the study period for severity of symptoms based on Canadian classification of angina guidelines and their treatment. Results: Severities of symptoms (timing of the chest pain, chest pain during walking and climbing a staircase, the effect of chest pain in day to day physical activities, frequency and the number of GTN used per week and frequency of consultation a doctor for chest pain) were significantly improved in the study group (p < 0.05, p < 0.01) after intervention. However, the control group did not show any significant changes (p > 0.05). Conclusion: Systematically, regular listening of music based on Indian classical system significantly improves the severity of the stable angina symptoms. Hence music has a potential benefit in considering for use as complementary to angina treatment in reducing morbidity.
文摘CHEK2 (Checkpoint kinase homolog 2) encodes a protein involved in pathways that arrest the cell cycle in response to genomic stress such as DNA damage or replication blocks. Carriers of some of the CHEK2 mutations are at an increased risk of breast cancer. A mutation in the kinase domain of the CHEK2 gene resulting in the R406H substitution has been reported. However, it is currently unknown whether the substitution alters the function of CHEK2 in vitro. We evaluated the effect of the R406H substitution on the normal function of CHEK2 using a yeast complementation assay. The yeast cells lacking Rad53, the yeast homologue of human CHEK2 were transformed with the wild type as well as plasmids carrying mutations resulting in the R406H, 1100delC, and S428F variants. Yeast cells carrying the R406H variant grew at a rate similar to those carrying the wild type CHEK2, whereas the yeast carrying the S428F and 1100delC mutants grew at a slower rate. These results suggest that, unlike the well-known pathogenic alleles such as 1100delC and S428F, the R406H substitution does not abrogate the function of CHEK2. Therefore, this variant is probably not important in development of breast cancer in women.
